Huberman Lab avatar

Dexa/Huberman Lab

Supported byHuberman Lab
Learn more

NMDA Receptors Explained

Explore the intriguing relationship between NMDA receptors and novel therapeutic compounds for major depression, such as ketamine and PCP. These substances, known for their dissociative effects, are being studied for their potential to alter emotional and perceptual states. Recent research highlights a common mechanism in the brain's neocortex, shedding light on how these compounds might provide relief for those suffering from depression.
  • In this clip

  • From this podcast

    Huberman Lab avatar

    Huberman Lab

    Understanding & Conquering Depression | Huberman Lab Podcast #34

  • Related Questions

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Neural Circuits of Depression?

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode "Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast" and the clip "Neural Circuits of Depression"?

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Neural Circuits of Depression?

Built by
Charlie AI
© 2024 Huberman LabTermsPrivacyDisclaimerSupport